Literature DB >> 3888840

Lack of antibacterial activity after intravenous hydrogen peroxide infusion in experimental Escherichia coli sepsis.

J L Shenep, D C Stokes, W T Hughes.   

Abstract

The intravenous administration of hydrogen peroxide has been reported to benefit patients with pneumonia and to reduce Plasmodium parasitemia in experimentally infected mice. We assessed the antibacterial activity of intravenously infused hydrogen peroxide against hydrogen peroxide-susceptible Escherichia coli (MBC of hydrogen peroxide, 0.23 mM) in experimentally infected rabbits. No decrease in the level of bacteremia was detected at the maximum intravenous infusion rate of hydrogen peroxide physiologically tolerated by the rabbits (2.0 mumol/h). Moreover, the addition ex vivo of greater amounts of hydrogen peroxide to human or murine blood containing E. coli resulted in no detectable antibacterial action. In contrast, ethyl hydrogen peroxide, which is not affected by catalase, was bactericidal when added ex vivo to human blood containing E. coli. These results suggest that extracellular hydrogen peroxide, whether of exogenous or endogenous origin, does not have antibacterial activity in the blood of animals having even low levels of catalase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888840      PMCID: PMC261202          DOI: 10.1128/iai.48.3.607-610.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Studies on the parenteral administration of hydrogen peroxide.

Authors:  A L LORINCZ; J J JACOBY; H M LIVINGSTONE
Journal:  Anesthesiology       Date:  1948-03       Impact factor: 7.892

2.  The use of hydrogen peroxide as a source of oxygen in a regional intra-arterial infusion system.

Authors:  J T MALLAMS; J W FINNEY; G A BALLA
Journal:  South Med J       Date:  1962-03       Impact factor: 0.954

3.  Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.

Authors:  J B Robbins; G H McCracken; E C Gotschlich; F Orskov; I Orskov; L A Hanson
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

4.  Improvement of leukocyte bactericidal activity in chronic granulomatous disease.

Authors:  R B Johnston; R L Baehner
Journal:  Blood       Date:  1970-03       Impact factor: 22.113

5.  Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.

Authors:  J L Shenep; K A Mogan
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

6.  The lung as a filter for microbubbles.

Authors:  B D Butler; B A Hills
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-09

7.  Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease.

Authors:  R L Baehner; D G Nathan; M L Karnovsky
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

8.  Possible pathogenic role of endotoxin in Reye's syndrome.

Authors:  M S Cooperstock; R P Tucker; J V Baublis
Journal:  Lancet       Date:  1975-06-07       Impact factor: 79.321

9.  Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.

Authors:  C F Nathan; S C Silverstein; L H Brukner; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.

Authors:  C F Nathan; L H Brukner; S C Silverstein; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Hydrogen peroxide and disease: towards a unified system of pathogenesis and therapeutics.

Authors:  Jay Pravda
Journal:  Mol Med       Date:  2020-05-07       Impact factor: 6.354

2.  Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury.

Authors:  Miklos Lipcsey; Maria Bergquist; Rebecca Sirén; Anders Larsson; Fredrik Huss; Jay Pravda; Mia Furebring; Jan Sjölin; Helena Janols
Journal:  Biomedicines       Date:  2022-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.